Low-Grade Prostate Cancer: Time to Stop Calling It Cancer
- 20 September 2022
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (27) , 3110-3114
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Impact of Ductal Carcinoma In Situ Terminology on Patient Treatment PreferencesJAMA Internal Medicine, 2013
- Risk of suicide in men with low-risk prostate cancerEuropean Journal of Cancer, 2013
- Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based StudyEuropean Urology, 2013
- Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer?Journal of Clinical Oncology, 2012
- Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?American Journal of Surgical Pathology, 2012
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2012
- Predicting 15-Year Prostate Cancer Specific Mortality After Radical ProstatectomyJournal of Urology, 2011
- Treatment Outcomes of Radical Prostatectomy in Potential Candidates for 3 Published Active Surveillance ProtocolsUrology, 2010
- Non‐invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification systemPathology International, 2009
- Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005JNCI: Journal of the National Cancer Institute, 2009